Obesity Management Market Report

Global and Region Obesity Management Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：202
  • REPORT CODE：GMM977175
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Obesity Management market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Obesity Managementmarket, defines the market attractiveness level of Obesity Management market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Obesity Management industry, describes the types of Obesity Management market, the applications of major players and the market size, and deeply analyzes the current situation of the global Obesity Management market and the development prospects and opportunities of Obesity Management industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Obesity Management market in Chapter 13.

    By Player:

    • Pfizer Inc

    • F Hoffmann-La Roche Ltd

    • Currax Pharmaceuticals LLC

    • Sanofi-Aventis

    • AstraZeneca

    • Teva Pharmaceutical Industries Ltd

    • Merck Sharp & Dohme Corp

    • Novo Nordisk

    • Rhythm Pharmaceuticals, Inc

    • Bayer AG

    • GlaxoSmithKline plc

    • Vivus

    By Type:

    • Peripherally Acting Drugs

    • Centrally Acting Drugs

    By End-User:

    • Hospital Pharmacies

    • Retail Pharmacies

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Obesity Management Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Obesity Management Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Obesity Management Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Obesity Management Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Obesity Management Market Analysis and Outlook to 2022

    • 7.1 Global Obesity Management Consumption (2017-2022)

    • 7.2 United States Obesity Management Consumption (2017-2022)

    • 7.3 Europe Obesity Management Consumption (2017-2022)

    • 7.4 China Obesity Management Consumption (2017-2022)

    • 7.5 Japan Obesity Management Consumption (2017-2022)

    • 7.6 India Obesity Management Consumption (2017-2022)

    • 7.7 South Korea Obesity Management Consumption (2017-2022)

    8 Region and Country-wise Obesity Management Market Analysis and Outlook to 2028

    • 8.1 Global Obesity Management Consumption Forecast (2022-2028)

    • 8.2 United States Obesity Management Consumption Forecast (2022-2028)

    • 8.3 Europe Obesity Management Consumption Forecast (2022-2028)

    • 8.4 China Obesity Management Consumption Forecast (2022-2028)

    • 8.5 Japan Obesity Management Consumption Forecast (2022-2028)

    • 8.6 India Obesity Management Consumption Forecast (2022-2028)

    • 8.7 South Korea Obesity Management Consumption Forecast (2022-2028)

    9 Global Obesity Management Market Outlook by Types and Applications to 2022

    • 9.1 Global Obesity Management Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Peripherally Acting Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Centrally Acting Drugs Consumption and Growth Rate (2017-2022)

    • 9.2 Global Obesity Management Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

    10 Global Obesity Management Market Outlook by Types and Applications to 2028

    • 10.1 Global Obesity Management Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Peripherally Acting Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Centrally Acting Drugs Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Obesity Management Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    11 Global Obesity Management Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Obesity Management Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Obesity Management Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Obesity Management Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Obesity Management Market Competitive Analysis

    • 14.1 Pfizer Inc

      • 14.1.1 Pfizer Inc Company Details

      • 14.1.2 Pfizer Inc Obesity Management Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Pfizer Inc Obesity Management Product and Service

    • 14.2 F Hoffmann-La Roche Ltd

      • 14.2.1 F Hoffmann-La Roche Ltd Company Details

      • 14.2.2 F Hoffmann-La Roche Ltd Obesity Management Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 F Hoffmann-La Roche Ltd Obesity Management Product and Service

    • 14.3 Currax Pharmaceuticals LLC

      • 14.3.1 Currax Pharmaceuticals LLC Company Details

      • 14.3.2 Currax Pharmaceuticals LLC Obesity Management Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Currax Pharmaceuticals LLC Obesity Management Product and Service

    • 14.4 Sanofi-Aventis

      • 14.4.1 Sanofi-Aventis Company Details

      • 14.4.2 Sanofi-Aventis Obesity Management Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Sanofi-Aventis Obesity Management Product and Service

    • 14.5 AstraZeneca

      • 14.5.1 AstraZeneca Company Details

      • 14.5.2 AstraZeneca Obesity Management Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 AstraZeneca Obesity Management Product and Service

    • 14.6 Teva Pharmaceutical Industries Ltd

      • 14.6.1 Teva Pharmaceutical Industries Ltd Company Details

      • 14.6.2 Teva Pharmaceutical Industries Ltd Obesity Management Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Teva Pharmaceutical Industries Ltd Obesity Management Product and Service

    • 14.7 Merck Sharp & Dohme Corp

      • 14.7.1 Merck Sharp & Dohme Corp Company Details

      • 14.7.2 Merck Sharp & Dohme Corp Obesity Management Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Merck Sharp & Dohme Corp Obesity Management Product and Service

    • 14.8 Novo Nordisk

      • 14.8.1 Novo Nordisk Company Details

      • 14.8.2 Novo Nordisk Obesity Management Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Novo Nordisk Obesity Management Product and Service

    • 14.9 Rhythm Pharmaceuticals, Inc

      • 14.9.1 Rhythm Pharmaceuticals, Inc Company Details

      • 14.9.2 Rhythm Pharmaceuticals, Inc Obesity Management Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Rhythm Pharmaceuticals, Inc Obesity Management Product and Service

    • 14.10 Bayer AG

      • 14.10.1 Bayer AG Company Details

      • 14.10.2 Bayer AG Obesity Management Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Bayer AG Obesity Management Product and Service

    • 14.11 GlaxoSmithKline plc

      • 14.11.1 GlaxoSmithKline plc Company Details

      • 14.11.2 GlaxoSmithKline plc Obesity Management Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 GlaxoSmithKline plc Obesity Management Product and Service

    • 14.12 Vivus

      • 14.12.1 Vivus Company Details

      • 14.12.2 Vivus Obesity Management Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Vivus Obesity Management Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Obesity Management

    • Figure Obesity Management Picture

    • Table Global Obesity Management Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Obesity Management Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Obesity Management Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Obesity Management Consumption by Country (2017-2022)

    • Figure United States Obesity Management Consumption and Growth Rate (2017-2022)

    • Table Europe Obesity Management Consumption and Growth Rate (2017-2022)

    • Figure China Obesity Management Consumption and Growth Rate (2017-2022)

    • Figure Japan Obesity Management Consumption and Growth Rate (2017-2022)

    • Figure India Obesity Management Consumption and Growth Rate (2017-2022)

    • Figure South Korea Obesity Management Consumption and Growth Rate (2017-2022)

    • Figure Global Obesity Management Consumption Forecast by Country (2022-2028)

    • Figure United States Obesity Management Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Obesity Management Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Obesity Management Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Obesity Management Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Obesity Management Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Obesity Management Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Peripherally Acting Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Centrally Acting Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Peripherally Acting Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Centrally Acting Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Obesity Management Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Obesity Management Export by Region (Top 5 Countries) (2017-2028)

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc Obesity Management Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Obesity Management Product and Service

    • Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Ltd Obesity Management Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd Obesity Management Product and Service

    • Table Currax Pharmaceuticals LLC (Foundation Year, Company Profile and etc.)

    • Table Currax Pharmaceuticals LLC Obesity Management Sales, Price, Value and Gross Profit (2017-2022)

    • Table Currax Pharmaceuticals LLC Obesity Management Product and Service

    • Table Sanofi-Aventis (Foundation Year, Company Profile and etc.)

    • Table Sanofi-Aventis Obesity Management Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi-Aventis Obesity Management Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Obesity Management Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Obesity Management Product and Service

    • Table Teva Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Industries Ltd Obesity Management Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Industries Ltd Obesity Management Product and Service

    • Table Merck Sharp & Dohme Corp (Foundation Year, Company Profile and etc.)

    • Table Merck Sharp & Dohme Corp Obesity Management Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Sharp & Dohme Corp Obesity Management Product and Service

    • Table Novo Nordisk (Foundation Year, Company Profile and etc.)

    • Table Novo Nordisk Obesity Management Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novo Nordisk Obesity Management Product and Service

    • Table Rhythm Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Rhythm Pharmaceuticals, Inc Obesity Management Sales, Price, Value and Gross Profit (2017-2022)

    • Table Rhythm Pharmaceuticals, Inc Obesity Management Product and Service

    • Table Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Bayer AG Obesity Management Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Obesity Management Product and Service

    • Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline plc Obesity Management Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline plc Obesity Management Product and Service

    • Table Vivus (Foundation Year, Company Profile and etc.)

    • Table Vivus Obesity Management Sales, Price, Value and Gross Profit (2017-2022)

    • Table Vivus Obesity Management Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US